Holen Sie sich die Stockscreener-App
0.8499
6.68%
0.0532
Handel nachbörslich:
.88
0.0301
+3.54%
Schlusskurs vom Vortag:
$0.7967
Offen:
$0.8
24-Stunden-Volumen:
1.50M
Relative Volume:
2.33
Marktkapitalisierung:
$44.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.22M
KGV:
-0.2871
EPS:
-2.96
Netto-Cashflow:
$-74.41M
1W Leistung:
+2.34%
1M Leistung:
+3.90%
6M Leistung:
+13.29%
1J Leistung:
-35.61%
1-Tages-Spanne:
$0.80
$0.88
1-Wochen-Bereich:
$0.7714
$0.8989
52-Wochen-Spanne:
$0.615
$1.70
Xilio Therapeutics Inc Stock (XLO) Company Profile
Firmenname
Xilio Therapeutics Inc
Sektor
Branche
Telefon
617-833-1027
Adresse
828 WINTER STREET, WALTHAM
Vergleichen Sie XLO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XLO
Xilio Therapeutics Inc
|
0.8499 | 41.29M | 0 | -81.22M | -74.41M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xilio Therapeutics Inc Stock (XLO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Eingeleitet | Leerink Partners | Outperform |
| 2022-12-21 | Eingeleitet | Chardan Capital Markets | Buy |
| 2022-01-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-16 | Eingeleitet | Cowen | Outperform |
| 2021-11-16 | Eingeleitet | Guggenheim | Buy |
| 2021-11-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-11-16 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Xilio Therapeutics Inc Aktie (XLO) Neueste Nachrichten
Xilio Therapeutics (Nasdaq: XLO) grants inducement option at $0.7967 with 10-year term - Stock Titan
How Xilio Therapeutics Inc. stock performs in high volatility marketsJuly 2025 Setups & Free Accurate Trade Setup Notifications - newser.com
Why Xilio Therapeutics Inc. stock is in analyst buy zone2025 Growth vs Value & Free Community Supported Trade Ideas - newser.com
Is it too late to sell Xilio Therapeutics Inc.Earnings Overview Summary & Weekly High Return Opportunities - newser.com
How Xilio Therapeutics Inc. stock compares to market leaders2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Xilio Therapeutics Inc expected to post a loss of 3 cents a shareEarnings Preview - TradingView
Tick level data insight on Xilio Therapeutics Inc. volatilityEarnings Miss & Community Verified Trade Signals - newser.com
Building trade automation scripts for Xilio Therapeutics Inc.July 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
Using data models to predict Xilio Therapeutics Inc. stock movementJuly 2025 Movers & Reliable Entry Point Alerts - newser.com
What Fibonacci levels say about Xilio Therapeutics Inc. reboundMarket Growth Report & Weekly Top Gainers Trade List - newser.com
Why analysts remain bullish on Xilio Therapeutics Inc. stockJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Tools to assess Xilio Therapeutics Inc.’s risk profileJuly 2025 Trends & Risk Managed Investment Signals - newser.com
What the charts say about Xilio Therapeutics Inc. todayJuly 2025 EndofMonth & Precise Swing Trade Entry Alerts - newser.com
What makes Xilio Therapeutics Inc. stock attractive to growth fundsJuly 2025 Intraday Action & Daily Stock Trend Reports - newser.com
Can Xilio Therapeutics Inc. stock deliver sustainable ROEPortfolio Gains Report & Stock Timing and Entry Methods - newser.com
Will Xilio Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com
Is Xilio Therapeutics Inc. stock a buy before product launchesJuly 2025 Reactions & Verified Stock Trade Ideas - newser.com
Is Xilio Therapeutics Inc a good long term investmentLong-Term Growth Stocks & Small Entry Cost Investments - earlytimes.in
Why Xilio Therapeutics Inc. stock remains on watchlists2025 Trading Volume Trends & Expert Curated Trade Setup Alerts - newser.com
Best data tools to analyze Xilio Therapeutics Inc. stockMarket Trend Review & AI Driven Stock Reports - newser.com
What machine learning models say about Xilio Therapeutics Inc.July 2025 Update & Safe Entry Zone Identification - newser.com
Volume spikes in Xilio Therapeutics Inc. stock – what they meanPortfolio Gains Summary & Fast Gain Swing Trade Alerts - newser.com
How geopolitical tensions affect Xilio Therapeutics Inc. stockProfit Target & Weekly Market Pulse Alerts - newser.com
Xilio to present vilastobart phase 2 data at SITC annual meeting - Investing.com Australia
Volatility clustering patterns for Xilio Therapeutics Inc.July 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Is Xilio Therapeutics Inc. stock safe for conservative investorsWeekly Profit Recap & Verified Momentum Stock Watchlist - newser.com
Finanzdaten der Xilio Therapeutics Inc-Aktie (XLO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):